Clinical trial
Malaria, Diabetes and Metabolic Syndrome: Investigating the Double Burden of Diseases in Cameroon
NCT05685875 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Malaria, Diabetes and Metabolic Syndrome: Investigating the Double Burden of Diseases in Cameroon
- Lead sponsor
- Karolinska Institutet
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 7, 2022
- Completion date
- June 30, 2023
- Enrollment
- 300 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, type 2, malaria,falciparum, metabolic syndrome, obesity, severe malaria